Last $234.86 USD
Change Today -0.94 / -0.40%
Volume 1.9M
AGN On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 8:04 PM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for allergan inc (AGN)

Year over year, Allergan Inc. has been able to grow revenues from $6.2B USD to $7.1B USD. Most impressively, the company has been able to reduce the percentage of sales devoted to income tax expense from 7.41% to 6.42%. This was a driver that led to a bottom line growth from $985.1M USD to $1.5B USD.
Currency in
Millions of US Dollars
As of:Dec 31
2011
Restated
Dec 31
2012
Restated
Dec 31
2013
Dec 31
2014
4 Year
Trend
Revenues5,144.05,549.36,188.97,114.6
Other Revenues72.097.3102.9111.8
TOTAL REVENUES5,216.05,646.66,291.87,226.4
Cost of Goods Sold718.0750.8778.2830.9
GROSS PROFIT4,498.04,895.85,513.66,395.5
Selling General & Admin Expenses, Total2,140.42,174.22,423.32,809.3
R&D Expenses871.5977.01,041.21,188.5
Depreciation & Amortization, Total86.190.2116.7112.4
OTHER OPERATING EXPENSES, TOTAL3,098.03,241.43,581.24,110.2
OPERATING INCOME1,400.01,654.41,932.42,285.3
Interest Expense-71.8-63.6-75.0-69.4
Interest and Investment Income6.96.76.87.7
NET INTEREST EXPENSE-64.9-56.9-68.2-61.7
Currency Exchange Gains (Loss)0.3-23.4-7.444.9
Other Non-Operating Income (Expenses)0.50.30.1-0.1
EBT, EXCLUDING UNUSUAL ITEMS1,335.91,574.41,856.92,268.4
Merger & Restructuring Charges-2.5-6.0-37.9-260.9
Gain (Loss) on Sale of Investments-1.3---3.0-3.1
Other Unusual Items, Total-22.9-37.4-85.2-15.1
Legal Settlements-3.4-9.7-3.1--
Other Unusual Items-11.9-5.4-70.7-15.1
EBT, INCLUDING UNUSUAL ITEMS1,309.21,531.01,730.81,989.3
Income Tax Expense359.6430.3458.3456.7
Minority Interest in Earnings-3.6-3.7-3.6-4.6
Earnings from Continuing Operations949.61,100.71,272.51,532.6
EARNINGS FROM DISCOUNTINUED OPERATIONS-11.51.8-283.8-3.8
NET INCOME934.51,098.8985.11,524.2
NET INCOME TO COMMON INCLUDING EXTRA ITEMS934.51,098.8985.11,524.2
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS946.01,097.01,268.91,528.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AGN:US $234.86 USD -0.94

AGN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Actavis plc $296.23 USD -1.08
Astellas Pharma Inc ¥1,980 JPY +3.00
Beiersdorf AG €77.77 EUR +0.62
Boston Scientific Corp $16.76 USD -0.30
Regeneron Pharmaceuticals Inc $412.51 USD -5.93
View Industry Companies
 

Industry Analysis

AGN

Industry Average

Valuation AGN Industry Range
Price/Earnings 46.9x
Price/Sales 9.7x
Price/Book 9.1x
Price/Cash Flow 43.3x
TEV/Sales 8.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALLERGAN INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.